(Bloomberg) -- Fidji Simo is joining OpenAI in a new role as chief executive officer of applications, reporting to Sam Altman, he announced on Wednesday.

Most Read from Bloomberg

The Battle Over the Fate of Detroit’s Renaissance Center Vail to Borrow Muni Debt to Ease Ski Resort Town Housing Crunch Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic? Iceland Plans for a More Volcanic Future

The 39-year-old executive will take over many of the AI startup’s operations, including finance, allowing Altman to focus on broader strategy.

Simo will oversee several executives who previously reported to Altman, according to a person with knowledge of the matter. Her reports will include Chief Operating Officer Brad Lightcap, Chief Financial Officer Sarah Friar and Chief Product Officer Kevin Weil, said the person, who asked not to be identified discussing non-public management changes. The research, safety, and scaling organizations will continue to report to Altman, the person said.

“In this new configuration I’ll be able to increase my focus on research, compute, and safety,” Altman said in a post on X. “These are critical as we approach superintelligence.”

Simo will depart her role as CEO of Maplebear Inc., the operator of Instacart, in the coming months, she said in a separate statement. She’s led the grocery delivery company for four years, following a decade at Meta Platforms Inc. OpenAI this week scaled back a proposed plan to reconfigure into a for-profit entity.

“In her new role, Fidji will focus on enabling our ‘traditional’ company functions to scale as we enter a next phase of growth,” Altman said in a statement posted to the OpenAI website. “We remain one OpenAI.”

Simo joined OpenAI’s board in early 2024 as part of a slate of new directors installed after the brief ousting and return of Altman in late 2023. Raised in France, she has spent years in leadership roles in the tech industry; before Instacart, she served as vice president and head of the Facebook app at Meta. She also co-founded a medical clinic and research foundation called the Metrodora Institute, which is aimed at curing neuroimmune disorders.

Instacart “expects that the company’s new CEO, who will be announced soon, will be one of its highly talented senior executives,” the company said in an emailed statement.

--With assistance from Dina Bass.

(Updates with additional details throughout)

Most Read from Bloomberg Businessweek

US Border Towns Are Being Ravaged by Canada’s Furious Boycott Pre-Tariff Car Buying Frenzy Leaves Americans With a Big Debt Problem Made-in-USA Wheelbarrows Promoted by Trump Are Now Made in China Inside the Dizzying Chaos of Running a Freight Business Under Trump Why Juggling IVF With Work Can Be a Career Killer

©2025 Bloomberg L.P.

View Comments